Cargando…

Sex differences in the MB49 syngeneic, murine model of bladder cancer

OBJECTIVE: The MB49 syngeneic, murine model of bladder cancer has been widely used for more than 35 years. In humans, bladder cancer is one third as prevalent in women as in men, with a trend toward lower prevalence in parous compared to nulliparous women. Our objective was to determine if the MB49...

Descripción completa

Detalles Bibliográficos
Autores principales:	White-Gilbertson, Shai, Davis, Megan, Voelkel-Johnson, Christina, Kasman, Laura M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795170/ https://www.ncbi.nlm.nih.gov/pubmed/26998503 http://dx.doi.org/10.14440/bladder.2016.73

Ejemplares similares

Adenoviral infectivity of exfoliated viable cells in urine: Implications for the detection of bladder cancer
por: Murali, Anuradha, et al.
Publicado: (2011)

A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line
por: Zhu, Yong-tong, et al.
Publicado: (2013)

Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model
por: Baloche, Valentin, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells
por: Kasman, Laura, et al.
Publicado: (2012)

Efficacy of instillation of MB49 cells and thermoreversible polymeric gel in urothelial bladder carcinoma immunization
por: Santana, Jhonne Pedro Pedott, et al.
Publicado: (2022)

Enhanced metastatic potential in the MB49 urothelial carcinoma model
por: Liu, Yu-Ru, et al.
Publicado: (2019)

Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice
por: Mirsaidi, Niely, et al.
Publicado: (2017)

Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model
por: Watanabe, Fábio T., et al.
Publicado: (2011)

Ceramide Synthase 6 Maximizes p53 Function to Prevent Progeny Formation from Polyploid Giant Cancer Cells
por: Lu, Ping, et al.
Publicado: (2021)

Optimization of a syngeneic murine model of bone metastasis
por: Farhoodi, Henry P., et al.
Publicado: (2020)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

Characterization of immune cell populations in syngeneic murine tumor models
por: Snipstad, Sofie, et al.
Publicado: (2023)

Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)
por: Bowers, Robert R., et al.
Publicado: (2022)

Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine
por: Zhu, Yong-tong, et al.
Publicado: (2015)

Concanavalin A potentiates syngeneic response in murine lymphocytes
Publicado: (1976)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
por: Chamo, Michael, et al.
Publicado: (2023)

In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe
por: Teranishi, Katsunori
Publicado: (2023)

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972)

IMMUNE AND NATURAL ANTIBODIES TO SYNGENEIC MURINE PLASMA CELL TUMORS
por: Herberman, Ronald B., et al.
Publicado: (1972)

Decidual-Placental Immune Landscape During Syngeneic Murine Pregnancy
por: Li, Yan, et al.
Publicado: (2018)

A murine preclinical syngeneic transplantation model for breast cancer precision medicine
por: Federico, Lorenzo, et al.
Publicado: (2017)

Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research
por: Evans, Jonathan P, et al.
Publicado: (2019)

Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
por: Russell, Shonagh, et al.
Publicado: (2022)

CD13/aminopeptidase N and murine cytomegalovirus infection
por: Kasman, Laura M.
Publicado: (2005)

Tamoxifen is a candidate first‐in‐class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells—Unrecognized players in tumorigenesis
por: White‐Gilbertson, Shai, et al.
Publicado: (2020)

Polyploid giant cancer cells are dependent on cholesterol for progeny formation through amitotic division
por: White-Gilbertson, Shai, et al.
Publicado: (2022)

Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction
Publicado: (1980)

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
por: Timmons, Joshua J., et al.
Publicado: (2016)

Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2021)

Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine
por: Wang, Chun‐yan, et al.
Publicado: (2017)

Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
por: Labrijn, Aran F., et al.
Publicado: (2017)

Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
por: Nolan, Kyle, et al.
Publicado: (2020)

Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model
por: Carlson, Peter M, et al.
Publicado: (2021)

Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer
por: Hamade, Ali, et al.
Publicado: (2022)

Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules
por: Glimcher, LH, et al.
Publicado: (1981)

Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2020)

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
por: Pepper, Andrew R., et al.
Publicado: (2015)

Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model
por: Yoshino, Takayuki, et al.
Publicado: (2019)

Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model
por: Brown, N J, et al.
Publicado: (2002)

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
por: Anker, Jonathan F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sbhgjmnm0oc29njcur8d1css4l